There were plenty of stocks which traded within a range on Wednesday and one such stock was that of MYND Life Sciences Inc. (OTCMKTS:MYNDF). Despite the fact that the stock was trading in a range, it should be noted that the company was actually in the news yesterday and it may be a good idea to take a look at the news.
Trading Data
On Wednesday, MYNDF stock ended flat at $0.16 with 30 shares, compared to its average volume of 358 shares. The stock has moved within a range of $0.1610 – 0.1610 after opening trade at $0.1610.
Provides Update on Depression Gene Modulation Pathway Patent Application
On Wednesday, the company announced that it had been successful in completing the National Phase filing of the Patent Cooperation Treaty application for a patent. In this regard, it is also important to point out that the company had in fact filed patent applications previously.
The patents in question were titled “A Method of Immune Modulation by Modulating a Specific Gene.” The Chief Executive Officer of the company Dr Lyle Oberg spoke about the latest move from the company as well.
He stated that MYND Life Sciences is quite different from the other companies which are involved in the psychedelic medicine space. It is actively looking for ways to protect its intellectual property and that is an important factor for investors who may be looking to invest in the stock. It remains to be seen if there is any move in the stock today or tomorrow.
Key Quote
“MYND’s is profoundly different than the majority of the Psychedelics’ sector. We are seeking intellectual property protection through the pursuit of patents by validation of our Intellectual Property through research and development,” stated Dr. Lyle Oberg, MD, CEO of MYND. “As this sector grows and matures and as MYND develops our novel drug development pipeline, the creation of a solid intellectual property portfolio is the key to creating lasting shareholder value. MYND’s ability to obtain patent protection will allow us to move towards the filing of Innovative New Drug (IND) application and approval status.”
